Private Placement

The Swedish freight-tech firm secures new funding for its SPAC merger, fueling a global push for its electric and autonomous trucking ecosystem.

Behind the success of iQIYI's new crime drama lies an AI powerhouse whose visual effects technology is quietly reshaping China's content landscape.

A complex, multi-currency financing deal highlights how non-bank lenders are enabling mid-market companies like Unicat to expand across international borders.

With promising data for its oral STAT6 degrader and a cash runway into 2029, Kymera Therapeutics is poised to disrupt the injectable-dominated market.

Eos Energy reports record revenue and a fortified balance sheet, resolving 'going concern' doubts, but sets 2026 guidance below analyst expectations.

Zoomcar's latest financing move involves complex warrants, raising questions about shareholder dilution and its strategy in India's car-sharing race.

DelphX Capital Markets raises fresh capital for its innovative structured notes, navigating weak financials and a competitive market for hybrid securities.

With a massive late-stage pipeline and deep pockets, the biotech aims to defeat elusive cancer targets, but soaring costs raise the stakes for pivotal trials.

With stellar clinical data and a full war chest, Terns is hitting the road to convince investors its leukemia drug, TERN-701, is a true disruptor.

Fresh off a pivot from fintech, T3 Defense lands $20M to acquire critical suppliers, aiming to fix bottlenecks in America's defense industrial base.

As autonomous agents and shadow AI run rampant, Symmetry's new platform offers unified visibility and control to prevent data loss and compliance chaos.

A landmark public-private partnership brings high-speed fiber internet to over 1,000 underserved homes and businesses in rural Southeastern Alabama.

With record growth and new security tools, Addigy is redefining Apple device management, challenging rivals and setting a new standard for IT teams.

Struggling biotech Jupiter Neurosciences presents its Parkinson's drug to elite investors at Mar-a-Lago, betting its hybrid business model can win funding.

Amid a volatile market, Rock Tech Lithium's latest funding from existing investors signals strong confidence in its strategy to build a local battery supply chain.

Aera Technology's 'agentic AI' lands on The Hackett Group's '50 to Watch' list, promising to automate complex supply chain decisions in real time.

Agassi Sports Entertainment hires MKTG to launch its AI-powered 'Agassi Intelligence' platform, aiming to revolutionize the booming racquet sports market.

A medical device firm is delegating its $163M Solana treasury, partnering with The Tie to forge a new path for institutional crypto adoption.

With promising preclinical data and Australian trial approval, Kivu’s KIVU-305 aims to overcome past failures in targeting aggressive solid tumors.

With its stock lagging, TScan Therapeutics will use a key conference to highlight upcoming clinical trial data and convince investors of its pipeline's value.